Cwm LLC Has $153,000 Position in Medifast, Inc. (NYSE:MED)

Cwm LLC lifted its position in shares of Medifast, Inc. (NYSE:MED) by 70.9% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,006 shares of the specialty retailer’s stock after purchasing an additional 3,322 shares during the period. Cwm LLC’s holdings in Medifast were worth $153,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in Medifast by 7.2% during the fourth quarter. Vanguard Group Inc. now owns 1,686,957 shares of the specialty retailer’s stock worth $113,397,000 after purchasing an additional 113,734 shares during the period. Renaissance Technologies LLC lifted its position in shares of Medifast by 20.3% in the second quarter. Renaissance Technologies LLC now owns 958,610 shares of the specialty retailer’s stock valued at $20,917,000 after buying an additional 161,487 shares during the last quarter. Millennium Management LLC boosted its stake in shares of Medifast by 37.8% during the 2nd quarter. Millennium Management LLC now owns 469,216 shares of the specialty retailer’s stock worth $10,238,000 after acquiring an additional 128,719 shares during the period. AQR Capital Management LLC increased its holdings in shares of Medifast by 117.5% during the 2nd quarter. AQR Capital Management LLC now owns 389,951 shares of the specialty retailer’s stock worth $8,509,000 after acquiring an additional 210,669 shares during the last quarter. Finally, Acadian Asset Management LLC increased its holdings in shares of Medifast by 2,000.1% during the 2nd quarter. Acadian Asset Management LLC now owns 338,228 shares of the specialty retailer’s stock worth $7,376,000 after acquiring an additional 322,123 shares during the last quarter. 95.51% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, DA Davidson reaffirmed an “underperform” rating and set a $17.50 price objective on shares of Medifast in a research report on Monday, July 22nd.

Medifast Stock Up 0.3 %

Medifast stock opened at $17.63 on Friday. The company’s 50-day moving average price is $18.58 and its two-hundred day moving average price is $21.87. The stock has a market cap of $192.87 million, a P/E ratio of 6.58 and a beta of 1.13. Medifast, Inc. has a twelve month low of $17.07 and a twelve month high of $76.42.

Medifast (NYSE:MED) last announced its earnings results on Monday, August 5th. The specialty retailer reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.56. The company had revenue of $168.56 million for the quarter, compared to analyst estimates of $160.44 million. Medifast had a return on equity of 25.77% and a net margin of 3.81%. During the same quarter last year, the company earned $2.77 earnings per share. Equities analysts anticipate that Medifast, Inc. will post 1.12 earnings per share for the current fiscal year.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.